US Patent Issued to Suzhou Pro-heal Pharmaceuticals technology on June 9 for "Anti-insulin-like growth factor 1 receptor (IGF-1R) antibodies and method of use thereof to treat thyroid-associated opthamology" (Chinese Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,795, issued on June 9, was assigned to Suzhou Pro-heal Pharmaceuticals technology Co. Ltd. (Jiangsu, China).

"Anti-insulin-like growth factor 1 receptor (IGF-1R) antibodies and method of use thereof to treat thyroid-associated opthamology" was invented by Shuhua Guo (Jiangsu, China), Lin Ma (Jiangsu, China) and Peng Zhang (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides an antibody that can bind IGF-1R. The antibody is composed of light chain and heavy chain. The light chain and heavy chain variable regions are one of the combinations of SEQ ID NO:2 and SEQ ID NO:3, SEQ ID NO:4 and SEQ ID NO:5, SEQ ID NO:6 and SEQ...